These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 33627137)

  • 1. Inhibition of the Otub1/c-Maf axis by the herbal acevaltrate induces myeloma cell apoptosis.
    Sun T; Xu Y; Xu Z; Cao B; Zhang Z; Wang Q; Kong Y; Mao X
    Cell Commun Signal; 2021 Feb; 19(1):24. PubMed ID: 33627137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-bacterial and anti-viral nanchangmycin displays anti-myeloma activity by targeting Otub1 and c-Maf.
    Xu Y; Sun T; Zeng K; Xu M; Chen J; Xu X; Zhang Z; Cao B; Tang X; Wu D; Kong Y; Zeng Y; Mao X
    Cell Death Dis; 2020 Sep; 11(9):818. PubMed ID: 32999280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting the Otub1/c-Maf axis for the treatment of multiple myeloma.
    Xu Y; Xu M; Tong J; Tang X; Chen J; Chen X; Zhang Z; Cao B; Stewart AK; Moran MF; Wu D; Mao X
    Blood; 2021 Mar; 137(11):1478-1490. PubMed ID: 32842143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mebendazole elicits potent antimyeloma activity by inhibiting the USP5/c-Maf axis.
    Chen XH; Xu YJ; Wang XG; Lin P; Cao BY; Zeng YY; Wang Q; Zhang ZB; Mao XL; Zhang T
    Acta Pharmacol Sin; 2019 Dec; 40(12):1568-1577. PubMed ID: 31197245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The ubiquitin-conjugating enzyme UBE2O modulates c-Maf stability and induces myeloma cell apoptosis.
    Xu Y; Zhang Z; Li J; Tong J; Cao B; Taylor P; Tang X; Wu D; Moran MF; Zeng Y; Mao X
    J Hematol Oncol; 2017 Jul; 10(1):132. PubMed ID: 28673317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The deubiquitinase USP7 stabilizes Maf proteins to promote myeloma cell survival.
    He Y; Wang S; Tong J; Jiang S; Yang Y; Zhang Z; Xu Y; Zeng Y; Cao B; Moran MF; Mao X
    J Biol Chem; 2020 Feb; 295(7):2084-2096. PubMed ID: 31822558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of the deubiquitinase USP5 leads to c-Maf protein degradation and myeloma cell apoptosis.
    Wang S; Juan J; Zhang Z; Du Y; Xu Y; Tong J; Cao B; Moran MF; Zeng Y; Mao X
    Cell Death Dis; 2017 Sep; 8(9):e3058. PubMed ID: 28933784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acevaltrate promotes apoptosis and inhibits proliferation by suppressing HIF-1α accumulation in cancer cells.
    Mi C; Zhang QL; Sun MJ; Lv Y; Sun QL; Geng SL; Wang TY
    Int Immunopharmacol; 2024 May; 133():112066. PubMed ID: 38615377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bruceine B Displays Potent Antimyeloma Activity by Inducing the Degradation of the Transcription Factor c-Maf.
    Li H; Zhu X; Sun Z; Wang Q; Song S; Xu Y; He G; Mao X
    ACS Pharmacol Transl Sci; 2024 Jan; 7(1):176-185. PubMed ID: 38230274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ubiquitin ligase HERC4 mediates c-Maf ubiquitination and delays the growth of multiple myeloma xenografts in nude mice.
    Zhang Z; Tong J; Tang X; Juan J; Cao B; Hurren R; Chen G; Taylor P; Xu X; Shi CX; Du J; Hou J; Wang G; Wu D; Stewart AK; Schimmer AD; Moran MF; Mao X
    Blood; 2016 Mar; 127(13):1676-86. PubMed ID: 26825710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of small compounds that inhibit multiple myeloma proliferation by targeting c-Maf transcriptional activity.
    Asano K; Kikuchi K; Takehara M; Ogasawara M; Yoshioka Y; Ohnishi K; Iwata A; Shimizu S; Tanaka M
    Biochem Biophys Res Commun; 2023 Dec; 684():149135. PubMed ID: 37879249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The transmembrane protein TMEPAI induces myeloma cell apoptosis by promoting degradation of the c-Maf transcription factor.
    Du Y; Liu Y; Xu Y; Juan J; Zhang Z; Xu Z; Cao B; Wang Q; Zeng Y; Mao X
    J Biol Chem; 2018 Apr; 293(16):5847-5859. PubMed ID: 29467225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CS1 promotes multiple myeloma cell adhesion, clonogenic growth, and tumorigenicity via c-maf-mediated interactions with bone marrow stromal cells.
    Tai YT; Soydan E; Song W; Fulciniti M; Kim K; Hong F; Li XF; Burger P; Rumizen MJ; Nahar S; Podar K; Hideshima T; Munshi NC; Tonon G; Carrasco RD; Afar DE; Anderson KC
    Blood; 2009 Apr; 113(18):4309-18. PubMed ID: 19196658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MAF protein mediates innate resistance to proteasome inhibition therapy in multiple myeloma.
    Qiang YW; Ye S; Chen Y; Buros AF; Edmonson R; van Rhee F; Barlogie B; Epstein J; Morgan GJ; Davies FE
    Blood; 2016 Dec; 128(25):2919-2930. PubMed ID: 27793878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of the USP10/CCND1 axis induces glioblastoma cell apoptosis.
    Sun T; Xu YJ; Jiang SY; Xu Z; Cao BY; Sethi G; Zeng YY; Kong Y; Mao XL
    Acta Pharmacol Sin; 2021 Aug; 42(8):1338-1346. PubMed ID: 33184448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of the Non-Coding RNA OTUB1-isoform 2 Contributes to Gastric Cancer Cell Proliferation and Invasion and Predicts Poor Gastric Cancer Prognosis.
    Wang YQ; Zhang QY; Weng WW; Wu Y; Yang YS; Shen C; Chen XC; Wang L; Liu KJ; Xu MD; Sheng WQ
    Int J Biol Sci; 2016; 12(5):545-57. PubMed ID: 27019636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ubiquitination of the transcription factor c-MAF is mediated by multiple lysine residues.
    Chen G; Xu X; Tong J; Han K; Zhang Z; Tang J; Li S; Yang C; Li J; Cao B; Zhou H; Wu D; Moran MF; Mao X
    Int J Biochem Cell Biol; 2014 Dec; 57():157-66. PubMed ID: 25448412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non-coding RNA ANGPTL1-3 promotes multiple myeloma bortezomib resistance by sponging miR-30a-3p to activate c-Maf expression.
    Nian F; Zhu J; Chang H
    Biochem Biophys Res Commun; 2019 Jul; 514(4):1140-1146. PubMed ID: 31103265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a promising PI3K inhibitor for the treatment of multiple myeloma through the structural optimization.
    Han K; Xu X; Chen G; Zeng Y; Zhu J; Du X; Zhang Z; Cao B; Liu Z; Mao X
    J Hematol Oncol; 2014 Jan; 7():9. PubMed ID: 24428908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deubiquitination of MYC by OTUB1 contributes to HK2 mediated glycolysis and breast tumorigenesis.
    Han X; Ren C; Lu C; Qiao P; Yang T; Yu Z
    Cell Death Differ; 2022 Sep; 29(9):1864-1873. PubMed ID: 35296795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.